There are different animal models to evaluate pain among them the formalin hind paw assay which is widely used since some of its events appear to be similar to the clinical pain of humans. The assay in which a dilute solution of formalin is injected into the dorsal hindpaw of a murine produces two ‘phases’ of pain behavior separated by a inactive period. The early phase (Phase I) is probably due to direct activation of nociceptors and the second phase (Phase II) is due to ongoing inflammatory input and central sensitization. Mice were used to determine the potency antinociceptive of piroxicam (1,3,10,and 30 mg/kg), parecoxib (0.3, 1,3,10 and 30 mg/kg), dexketoprofen (3,10,30 and 100 mg/kg) and ketoprofen (3,10,30 and 100 mg/kg). Dose-response for each NSAIDs were created before and after 5 mg/kg of L-NAME i.p. or 5 mg/kg i.p. of 7-nitroindazole. A least-squares linear regression analysis of the log dose–response curves allowed the calculation of the dose that produced 50% of antinociception (ED50) for each drug. The ED50 demonstrated the following rank order of potency, in the phase I: piroxicam > dexketoprofen > ketoprofen > parecoxib and in the phase II: piroxicam > ketoprofen > parecoxib > dexketoprofen. Pretreatment of the mice with L-NAME or 7-nitroindazol induced a significant increase of the analgesic power of the NSAIDs, with a significant reduction of the ED50. It is suggested that NO may be involved in both phases of the trial, which means that nitric oxide regulates the bioactivity of NSAIDs.
2
Dubuisson D,
Dennis SG.
The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-174
8
Paul-Clark MJ,
Gilroy DW,
Willis D.
et al. Nitric xide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J Immunol 2001; 166: 1169-1177
10
Moore PK,
Wallace P,
Gaffen Z.
et al. Characterization of the novel nitric oxide synthase inhibitor 7-nitroindazole and related indazoles: Antinociceptive and cardiovascular effects. Br J Pharmacol 1993; 110: 219-224
14
Sakurada C,
Sugiyama A,
Nakayama M.
et al. Antinociceptive effect of spinally injected L-NAME on the acute nociceptive response induced by low concentrations of formalin. Neurochem Int 2001; 38: 417-423
15
Miranda HF,
Puig MM,
Dursteler C.
et al. Dexketoprofen-induced antinociception in animal models of acute pain: Synergy with morphine and paracetamol. Neuropharmacology 2007; 52: 291-296
16
Moore PK,
Wallace P,
Gaffen Z.
et al. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects.Br. J. Pharmacol 1993; 110: 219-224
17
Zhao YQ,
Wang HY,
Yin JB.
et al. The analgesic effects of celecoxib on the formalin-induced short- and long-term inflammatory pain. Pain Physician 2017; 20: 575-584
19
Mehanna MM,
Domiati S,
Nakkash Chmaisse H.
et al. Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway. Toxicol Appl Pharmacol 2018; 352: 170-175
21
Aguirre-Bañuelos P,
Granados-Soto V.
Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test. Eur J Pharmacol 2000; 395: 9-13
22
Ortiz MI,
Granados-Soto V,
Castañeda-Hernández G.
The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 2003; 76: 187-195
23
Ghorbanzadeh B,
Kheirandish V,
Mansouri MT.
Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP Channel Pathway and PPARγ Receptors in the Peripheral Antinociceptive Effect of Carbamazepine. Drug Res (Stuttg). 2019;
24
Bujalska-Zadrożny M,
Wolińska R,
Leśniak A.
et al. Central antinociceptive effect of tapentadol is increased by nitric oxide synthase inhibitors. Behav Pharmacol 2016; 27: 606-614
25
Rangel RA,
Marinho BG,
Fernandes PD.
et al Pharmacological mechanisms involved in the antinociceptive effects of dexmedetomidine in mice. Fundam Clin Pharmacol 2014; 28: 104-113
26
Dudhgaonkar SP,
Kumar D,
Naik A.
et al. Interaction of inducible nitric oxide synthase and cyclooxygenase-2 inhibitors in formalin-induced nociception in mice. Eur J Pharmacol 2004; 492: 117-122
27
Dableh LJ,
Henry JL.
The selective neuronal nitric oxide synthase inhibitor 7-nitroindazole has acute analgesic but not cumulative effects in a rat model of peripheral neuropathy. J Pain Res 2011; 4: 85-90
28
Romero TR,
Resende LC,
Duarte ID.
The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs. Nitric Oxide 2011; 25: 431-435
30
Miranda HugoF.,
Noriega Viviana,
Sierralta Fernando.
et al. Non-steroidal anti-inflammatory drugs in tonic, phasic and inflammatory mouse models: Drug Research. 2019;
